Old Age, B Cell Function and Count Are the Critical Factors for Predicting Infection Risk in Patients With Autoimmune Rheumatic Diseases Undergoing Immunosuppression: A Cohort Study

被引:0
|
作者
Prakruthi, Jaladhar [1 ]
Kori, Devaraj [1 ]
Paramshetti, Shruti [1 ]
Ahamed, Sayid Fahad Nizar [1 ]
Panchagnula, Renuka [2 ]
Chandrashekara, S. [1 ]
机构
[1] Chanre Rheumatol & Immunol Ctr & Res, Bengaluru, Karnataka, India
[2] ChanRe Diagnost Lab, Bengaluru, Karnataka, India
关键词
ARD; IgG; immunosuppression; infection risk; neutrophil count; predictive parameters; TO-LYMPHOCYTE RATIO; TRANSPLANTATION; MANAGEMENT; NEUTROPHIL; SOCIETY; COMPLICATIONS; BIOMARKERS; MORTALITY;
D O I
10.1111/1756-185X.70187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The study aims to assess baseline immune parameters that predict infection risk in autoimmune rheumatic disease (ARD) patients, with the goal of identifying high-risk individuals requiring immunosuppressive therapy escalation, based on infection rates during a one-year follow-up. Methods: The independent cohort study was conducted at a tertiary rheumatology center in India from December 2019 to March 2022. It included adult participants with ARDs undergoing immunosuppression. Ethics approval and informed consent were obtained. Patients underwent detailed history, clinical examination, and baseline investigations, which included complete hemogram, inflammatory parameters, immunoglobulin levels, cellular levels of the immune system, complement levels, and viral markers. Descriptive statistics, ANOVA, chi-squared tests, t-tests, and Fisher's exact tests were used. OLS regression analyses identified significant predictors of infection risk. They were followed up for a period of 1 year for any infection episodes. Results: Of the 106 participants recruited, 4 were excluded due to disease-related complications during the 3-month period of follow-up. The mean age of the participants was 38.21 +/- 12.73 years, with an average follow-up duration of 13.1 +/- 8.35 months. Among the remaining 102 participants, younger age was associated with a lower infection risk (OR 1.047). Protective factors against infection included lower levels of immunoglobulin E (IgE) (OR 0.379), methotrexate (MTX) use (OR 0.247), and biologics (OR 0.543). Conversely, lower Immunoglobulin G (IgG), elevated neutrophil counts (OR 3.588), higher neutrophil-to-lymphocyte ratios (NLR) (OR 2.577), low platelet counts (OR 0.546), and steroid use, which increased the risk fivefold (OR 5.686), were identified as risk factors. Ordinary Least Squares (OLS) regression analysis highlighted age, IgG levels, CD19 lymphocyte counts, WBC counts, and ESR as significant predictors of infection risk between the groups. Conclusion: Older age, low IgG, low B cell count (CD19) predict susceptibility to infections; high neutrophil counts, low platelets, and elevated NLR are key predictors of developing infection in ARDs patients. Careful monitoring and tailored treatment strategies are essential to reduce infection risks. Further research is needed in this direction to develop predictive algorithms.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Prevalence of Occult Hepatitis B Carrier Status and Its Associated Risk Factors in Patients with Rheumatic Diseases Undergoing Biological Therapies
    Mok, Chi Chiu
    Ho, Ling Yin
    Chan, Kar Li
    Tse, Sau Mei
    To, Chi Hung
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [22] RISK FACTORS FOR CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH RHEUMATIC DISEASE; SINGLE-CENTER PROSPECTIVE COHORT STUDY.
    Ota, Y.
    Kondo, Y.
    Saito, S.
    Kikuchi, J.
    Hanaoka, H.
    Kaneko, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 919 - 919
  • [23] Perioperative and anesthetic risk factors of surgical site infection in patients undergoing pancreaticoduodenectomy: A retrospective cohort study
    Yamamoto, Saori
    Nagamine, Yusuke
    Miyashita, Tetsuya
    Ito, Shiono
    Iwasawa, Yurika
    Kawai, Michihiko
    Saito, Shinsaku
    Tamai, Tomohisa
    Goto, Takahisa
    PLOS ONE, 2020, 15 (10):
  • [24] Serious Infection Risk in Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Rheumatic Diseases: A US National Cohort Study
    Mehta, Bella Y.
    Pedro, Sofia
    Ozen, Gulsen
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [25] Clinical Course and Risk Factors for Severe/Critical COVID-19 in Patients with Rheumatic Diseases - a Multicenter, Nationwide Study
    Barreira, Sofia Carvalho
    Cruz-Machado, Ana Rita
    Bandeira, Matilde
    Duarte, Catarina
    Rato, Maria
    Fernandes, Bruno
    Garcia, Salome
    Pinheiro, Filipe
    Bernardes, Miguel
    Madeira, Nathalie
    Miguel, Claudia
    Torres, Rita
    Silva, Ana Bento
    Pestana, Jorge
    Almeida, Diogo
    Mazeda, Carolina
    Santos, Filipe Cunha
    Pinto, Patricia
    Sousa, Marlene
    Parente, Hugo
    Sequeira, Graca
    Santos, Maria Jose
    Fonseca, Joao Eurico
    Romao, Vasco C.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3234 - 3238
  • [26] RISK FACTORS FOR SEVERE INFECTION AND OUTCOME OF SECONDARY HYPOGAMMAGLOBULINAEMIA IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS FROM 400 PATIENTS AT A SINGLE CENTRE
    Yusof, M. Y. Md
    Hensor, E. M.
    Das, S.
    Vital, E. M.
    Emery, P.
    Savic, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 845 - 845
  • [27] Clinical outcomes and risk factors in patients with COVID-19 and autoimmune rheumatic diseases: insights from a major Australian hospital study
    Ling, Zhi
    Guy, Stephen
    Fong, Christopher
    INTERNAL MEDICINE JOURNAL, 2024, 54 (10) : 1634 - 1643
  • [28] Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational study
    Lazarou, Ilias
    Finckh, Axel
    Fischer, Lara
    Ribi, Camillo
    Gascon, Danielle
    Seebach, Jorg D.
    Guerne, Pierre-Andre
    JOINT BONE SPINE, 2016, 83 (02) : 191 - 197
  • [29] BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study
    Bieber, Amir
    Sagy, Iftach
    Novack, Lena
    Brikman, Shay
    Abuhasira, Ran
    Ayalon, Snait
    Novofastovski, Irina
    Abu-Shakra, Mahmoud
    Mader, Reuven
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (07) : 1028 - 1035
  • [30] Hemorrhages and risk factors in patients undergoing thromboprophylaxis in a respiratory critical care unit: a secondary data analysis of a cohort study
    Lyu, Wen-Rui
    Tang, Xiao
    Jin, Yu
    Wang, Rui
    Li, Xu-Yan
    Li, Ying
    Zhang, Chun-Yan
    Zhao, Wei
    Tong, Zhao-Hui
    Sun, Bing
    JOURNAL OF INTENSIVE CARE, 2024, 12 (01):